Cardiac risk factors and the use of triptans: A survey study

Headache

Volumn 40, Issue 7, 2000, Pages 587-591

  Young, William B ^a   Mannix, Lisa ^b   Adelman, James U ^b   Shechter, Aaron L ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b Headache Wellness Center   (United States)

Author keywords

Cardiac risk factors; Dihydroergotamine; Migraine; Myocardial infarction; Triptans

Indexed keywords

DIHYDROERGOTAMINE; SEROTONIN AGONIST;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DRUG CONTRAINDICATION; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FAMILY PRACTICE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK FACTORS; SEROTONIN AGONISTS; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 0033916915     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2000.00091.x     Document Type: Article

References (6)

1. Visser WH, Jaspers NM, deVriend RH, Ferrari MD. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia. 1996;16:264-269.
2. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996;36:329-331.
3. 1B/1D agonists - is there a cause for concern? Cephalalgia. 1998;18:539-545.
4. Cavazos JE, Caress JB, Chilukuri VR, Devlin T, Gray L, Hurwitz BJ. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 1994;343:1105-1106.
5. Nighoghossian N, Derex L, Trouillas P. Multiple intracerebral hemorrhages and vasospasm following antimigrainous drug abuse. Headache. 1998;38:478-480.
6. Knudsen JF, Friedman B, Chen M, Goldwasser JE. Ischemic colitis and sumatriptan use. Arch Intern Med. 1998;158:1946-1948.